Janice Schwartz Spoke on Panel Discussing Challenges to Diversifying Clinical Trials

Janice Schwartz, MD spoke on a panel discussing regulatory challenges to diversifying clinical trials with former FDA officials on Monday, March 29, 2021 at the National Academies of Science, Engineering and Medicine Workshop entitled “Overcoming barriers to diversifying clinical trials: lessons learned from regulatory agencies, industry, and federal and private funders." The Workshop was organized by the Committee on improving the representation of women and underrepresented minorities in clinical trials and research.